https://www.eurekalert.org/news-releases/1003635
0
0
CARB-X is funding a University of Melbourne research team to develop an oral therapeutic to treat drug-resistant community-acquired bacterial pneumonia - EurekAlert
10/4/23 at 2:00am
Organization
EurekAlert
Authors
Details
62 words
Summarize
Health CARB-X University of Melbourne Peter Doherty Institute for Infection and Immunity The Peter Doherty Institute for Infection and Immunity
<p>Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is awarding US$1.75 million to the University of Melbourne at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) to develop an oral therapeutic that rest…
Create an account or login to join the discussion